Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
AdvanSix Inc. (ASIX) Insider Trading Activity
Basic Materials • Chemicals • 1,450 employees
AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Total Value
-$1,593,745.44
Total Shares
93,743
Average Trade Value
-$45,535.58
Most Active Insider
Kane Erin N
Total Activity: $1,372,785
Largest Single Transaction
$616,411
by Kane Erin N on Feb 28, 2025
30-Day Activity
11 Transactions
Volume: 84,004 shares
Value: $1,004,467
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Svp, General Counsel
Officer
|
Mar 3, 2025 | 4,000 | $111,000 | 40,363 (-9.9%) | Sale | |
|
Svp, General Counsel
Officer
|
Feb 28, 2025 | 4,731 | $131,285 | 28,507 (-16.6%) | Payment of Exercise Price | |
|
Controller
Officer
|
Feb 28, 2025 | 9,010 | $0 | 54,521 (+16.5%) | Grant | |
|
SVP Chief Financial Officer
Officer
|
Feb 28, 2025 | 14,415 | $0 | 40,852 (+35.3%) | Grant | |
|
Svp, General Counsel
Officer
|
Feb 28, 2025 | 15,856 | $0 | 44,363 (+35.7%) | Grant | |
|
Controller
Officer
|
Feb 28, 2025 | 3,982 | $0 | 45,511 (+8.7%) | Grant | |
|
Controller
Officer
|
Feb 28, 2025 | 1,934 | $53,669 | 41,529 (-4.7%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 64,865 | $0 | 545,447 (+11.9%) | Grant | |
|
Svp, Chief Hr Officer
Officer
|
Feb 28, 2025 | 12,073 | $0 | 47,968 (+25.2%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 22,213 | $616,411 | 480,582 (-4.6%) | Payment of Exercise Price | |
|
Svp, Chief Hr Officer
Officer
|
Feb 28, 2025 | 3,319 | $92,102 | 35,895 (-9.2%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 3, 2025 | 600 | $18,426 | 502,795 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 3, 2025 | 4,400 | $132,528 | 503,395 (-0.9%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Jan 2, 2025 | 4,700 | $132,070 | 508,095 (-0.9%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Jan 2, 2025 | 300 | $8,670 | 507,795 (-0.1%) | Sale | |
|
Director
|
Dec 16, 2024 | 1,559 | $47,487 | 80,228 (+1.9%) | Grant | |
|
Director
|
Dec 16, 2024 | 430 | $13,098 | 27,893 (+1.5%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Dec 2, 2024 | 5,000 | $161,450 | 512,795 (-1.0%) | Sale | |
|
Controller
Officer
|
Nov 25, 2024 | 1,951 | $62,432 | 43,463 (-4.5%) | Sale | |
|
Controller
Officer
|
Nov 25, 2024 | 1,951 | $27,880 | 45,414 (+4.3%) | Exercise/Conversion | |
|
Director
|
Nov 18, 2024 | 5,030 | $149,089 | 5,030 (+100.0%) | Purchase | |
|
Controller
Officer
|
Nov 7, 2024 | 505 | $16,160 | 43,463 (-1.2%) | Sale | |
|
Controller
Officer
|
Nov 7, 2024 | 505 | $7,216 | 43,968 (+1.1%) | Exercise/Conversion | |
|
Controller
Officer
|
Nov 6, 2024 | 2,435 | $34,796 | 45,898 (+5.3%) | Exercise/Conversion | |
|
Controller
Officer
|
Nov 6, 2024 | 2,435 | $77,920 | 43,463 (-5.6%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 1, 2024 | 1,500 | $46,305 | 517,795 (-0.3%) | Sale | |
|
Svp, General Counsel
Officer
|
Nov 1, 2024 | 363 | $11,253 | 33,238 (-1.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 1, 2024 | 3,500 | $105,525 | 519,295 (-0.7%) | Sale | |
|
Controller
Officer
|
Oct 4, 2024 | 270 | $8,640 | 43,463 (-0.6%) | Sale | |
|
Controller
Officer
|
Oct 4, 2024 | 270 | $3,858 | 43,733 (+0.6%) | Exercise/Conversion | |
|
SVP Chief Financial Officer
Officer
|
Oct 1, 2024 | 26,437 | $10,000 | 26,437 (+100.0%) | Grant | |
|
Svp, General Counsel
Officer
|
Oct 1, 2024 | 350 | $10,563 | 33,601 (-1.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Oct 1, 2024 | 5,000 | $151,400 | 522,795 (-1.0%) | Sale | |
|
Director
|
Sep 30, 2024 | 432 | $13,124 | 27,412 (+1.6%) | Grant | |
|
Director
|
Sep 30, 2024 | 1,564 | $47,514 | 78,497 (+2.0%) | Grant |